Molecular typing is predicated on molecular genetic screening and is not yet routinely offered. Molecular subtypes and immunohistochemical surrogate markers with the tumors (HR, HER2, triple destructive) correlate in about 70%. The differentiation of luminal A and B subtypes by HR status and proliferation markers like Ki-67 could possibly https://billg875xhq5.qodsblog.com/profile